Arcadia Biosciences, Inc. (RKDA)
NASDAQ: RKDA · Real-Time Price · USD
2.988
-0.042 (-1.40%)
Apr 23, 2025, 4:00 PM EDT - Market closed

Arcadia Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
48372334
Upgrade
Market Cap Growth
132.51%132.51%-47.96%-71.05%-32.20%-28.18%
Upgrade
Enterprise Value
-02-11-14-834
Upgrade
Last Close Price
2.995.923.1310.8441.60101.20
Upgrade
PS Ratio
0.811.600.781.343.404.24
Upgrade
PB Ratio
0.661.300.270.320.741.19
Upgrade
P/TBV Ratio
0.661.310.270.320.751.26
Upgrade
EV/Sales Ratio
-0.34---4.24
Upgrade
Debt / Equity Ratio
0.030.030.080.100.110.33
Upgrade
Asset Turnover
0.300.300.180.140.150.20
Upgrade
Inventory Turnover
3.233.231.941.062.183.16
Upgrade
Quick Ratio
2.112.113.385.205.964.29
Upgrade
Current Ratio
3.613.614.176.037.025.02
Upgrade
Return on Equity (ROE)
-45.62%-45.62%-31.72%-14.62%-54.01%-32.68%
Upgrade
Return on Assets (ROA)
-28.06%-28.06%-15.04%-12.38%-33.30%-26.92%
Upgrade
Return on Capital (ROIC)
-46.41%-46.41%-19.96%-15.71%-41.98%-44.39%
Upgrade
Earnings Yield
-172.32%-87.10%-402.29%-230.24%-63.54%-13.68%
Upgrade
FCF Yield
-236.10%-119.34%-440.21%-210.37%-116.48%-95.66%
Upgrade
Buyback Yield / Dilution
-10.22%-10.22%-106.37%-12.66%-113.68%-56.51%
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q